Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine
Author:
Affiliation:
1. Chaithanya Eye Hospital and Research Institute, Kesavadasapuram, Trivandrum, Kerala, India
2. Chaithanya Eye Hospital and Research Institute, Tiruvalla, Kerala, India
Publisher
American Medical Association (AMA)
Subject
Ophthalmology
Link
https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2771168/jamaophthalmology_kurian_2020_oi_200071_1604337622.10066.pdf
Reference23 articles.
1. What is the actual prevalence of migraine?;Yeh;Brain Behav,2018
2. Prevalence, burden, and risk factors of migraine: a community-based study from Eastern India.;Ray;Neurol India,2017
3. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.;Global Burden of Disease Study 2013 Collaborators;Lancet,2015
4. Pharmacological approaches to migraine.;Diener;J Neural Transm Suppl,2003
5. Migraine—current understanding and treatment.;Goadsby;N Engl J Med,2002
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods;Pharmaceuticals;2024-01-11
2. Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye;Journal of Neuroscience and Neurological Disorders;2023-11-09
3. QuEChERS-assisted ion pair chromatography/fluorescence detection method for determination of antimigraine combination therapy in rabbit plasma samples: Application to a pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2023-10
4. Central Nervous System Disorders and Food and Drug Administration–Approved Drugs;Phytochemical Drug Discovery for Central Nervous System Disorders;2023-06-30
5. Migraine relief in 20 minutes using eyedrops?;The Journal of Family Practice;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3